Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Biodesix (BDSX) Income from Continuing Operations (2019 - 2025)

Biodesix's Income from Continuing Operations history spans 7 years, with the latest figure at 4026000.0 for Q4 2025.

  • For Q4 2025, Income from Continuing Operations rose 52.08% year-over-year to 4026000.0; the TTM value through Dec 2025 reached 35589000.0, up 16.76%, while the annual FY2025 figure was 35589000.0, 16.76% up from the prior year.
  • Income from Continuing Operations reached 4026000.0 in Q4 2025 per BDSX's latest filing, up from 9125000.0 in the prior quarter.
  • In the past five years, Income from Continuing Operations ranged from a high of 4026000.0 in Q4 2025 to a low of 18764000.0 in Q1 2023.
  • Average Income from Continuing Operations over 5 years is 11666450.0, with a median of 11509500.0 recorded in 2021.
  • Peak YoY movement for Income from Continuing Operations: crashed 292.35% in 2021, then soared 52.08% in 2025.
  • A 5-year view of Income from Continuing Operations shows it stood at 13175000.0 in 2021, then fell by 24.78% to 16440000.0 in 2022, then surged by 44.05% to 9199000.0 in 2023, then grew by 8.67% to 8401000.0 in 2024, then skyrocketed by 52.08% to 4026000.0 in 2025.
  • Per Business Quant, the three most recent readings for BDSX's Income from Continuing Operations are 4026000.0 (Q4 2025), 9125000.0 (Q3 2025), and 11617000.0 (Q2 2025).